Effects of Bailout Tirofiban on In-Hospital Outcomes and Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention
Angiology, cilt.70, sa.5, ss.431-439, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 70 Sayı: 5
- Basım Tarihi: 2019
- Doi Numarası: 10.1177/0003319718808911
- Dergi Adı: Angiology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.431-439
- Anahtar Kelimeler: ST-segment elevation myocardial infarction, primary percutaneous intervention, glycoprotein IIb, IIIa receptor antagonist, tirofiban, bailout
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
We retrospectively analyzed short- and long-term outcomes of patients who received bailout tirofiban during primary percutaneous intervention (pPCI). A total of 2681patients who underwent pPCI between 2009 and 2014 were analyzed; 1331 (49.6%) out of 2681 patients received bailout tirofiban. Using propensity score matching, 2100 patients (1050 patient received bail-out tirofiban) with similar preprocedural characteristics were identified. Patients who received bailout tirofiban had a significantly higher incidence of acute stent thrombosis, myocardial infarction, and major cardiac or cerebrovascular events during the in-hospital period. There were numerically fewer deaths in the bailout tirofiban group in the unmatched cohort (1.7% vs 2.5%, P =.118). In the matched cohort, in-hospital mortality was significantly lower (1.1% vs 2.4%, P =.03), and survival at 12 and 60 months were higher (96.9% vs 95.2%, P =.056 for 12 months and 95.1% vs 92.0%, P =.01 for 60 months) in the bailout tirofiban group. After multivariate adjustment, bailout tirofiban was associated with a lower mortality at 12 months (odds ratio [OR]: 0.554, 95% confidence interval [CI], 0.349-0.880, P =.012) and 60 months (OR: 0.595, 95% CI, 0.413-0.859, P =.006). In conclusion, bailout tirofiban strategy during pPCI is associated with a lower short- and long-term mortality, although in-hospital complications were more frequent.